Boralex’s Private Deal Premium Faces Growing Operational Risks

The market's bullish view on Boralex is starkly priced for perfection. The consensus analyst price target implies a forecasted upside of 47.02% from recent levels, a premium that demands flawless execution. Yet the company's most recent operational reality presents a clear expectations gap. In its fourth quarter, Boralex reported a 77.01% negative surprise on EPS, with earnings of just C$0.13 against a forecast of C$0.5654. Revenue also missed, coming in at C$241 million versus a C$277.53 million expectation.

This is the tension. Despite these significant misses, the stock's reaction was muted, with shares showing a modest increase of 0.35% in pre-market trading. That tepid response suggests investors are looking past the immediate disappointment, perhaps focusing on longer-term catalysts like its substantial project pipeline or improved liquidity. But it also reveals a market sentiment that has already discounted a lot of bad news. The bullish price target assumes the company will not only recover from these misses but also deliver on its ambitious future guidance, which includes projected EPS growth to C$6.55 in FY2026.

Viewed another way, the setup leaves little room for error. The consensus view appears to be that private deal speculation is a near-term inevitability, and the stock is being bid up in anticipation of a premium. However, the recent financial performance shows the underlying business is under pressure, with declining short-term contract prices in France and lower-than-expected production levels directly impacting results. If the company cannot quickly resolve these headwinds, the premium priced into the stock may be entirely unwarranted. For now, the market is pricing in a best-case resolution to the deal rumors, while the operational data hints at a more complex reality.

The Growth Engine: Capacity Expansion and Financial Flexibility

The private deal speculation is fundamentally a bet on Boralex's growth narrative. The company's strategy is clear and ambitious: to double its installed capacity by the end of the decade. This plan is not theoretical. In fiscal 2025, Boralex executed on it, expanding its capacity by 615 MW to reach 3.8 GW. The recent acquisition of a 338MW pipeline of renewables and energy storage developments in the UK, along with two specific wind projects, demonstrates the active, capital-intensive pursuit of that goal. The company is moving beyond organic growth to acquire ready-made projects, a move that accelerates its footprint but also increases its capital requirements.

This aggressive expansion has always been financed through a mix of debt and equity. A key precedent is the $175 million bought deal offering in 2020, which was explicitly used to fund the company's development pipeline and future acquisitions. That deal provided a significant capital injection at a time of high growth, but it also diluted shareholders. The pattern is clear: the growth engine requires sustained external financing. Each new project, whether developed in-house or acquired, demands cash for construction, permitting, and grid connection.

The financial flexibility Boralex reports is a direct result of this ongoing capital-raising effort. The company points to available liquidity increasing to 681 million CAD, a 23% rise from the prior year. This improved balance sheet is a necessary buffer, but it also highlights the capital intensity of the business. The liquidity boost likely stems from recent financings, including the 2020 deal and potentially others since. The risk is that this cycle of raising money to fund growth could repeat, creating a dependency that a private buyer might seek to break or, conversely, that could pressure the company's financials if market conditions tighten.

In practice, this means the growth story is a double-edged sword for the private deal thesis. On one hand, a buyer would inherit a company with a substantial, expanding asset base and a clear path to scale. On the other, they would also inherit the ongoing need for capital. The company's recent financial performance, with its declining short-term contract prices in France and production misses, shows that generating cash from operations to fund this expansion is not guaranteed. The premium priced into the stock assumes the company will successfully navigate this capital-intensive phase without a major financial stumble. If the growth engine requires more frequent equity raises or carries a heavier debt load, the calculus for a private buyer-and the stock's valuation-could shift significantly.

Valuation and the Private Deal Premium

The current public market valuation presents a clear puzzle for the going-private thesis. The stock is trading at $30.70, up 8.63% recently. This premium is the very reason for the speculation. Yet, for a private buyer to succeed, they would need to offer a significant additional premium over this already elevated price to attract shareholder support. The market is not pricing in a simple deal; it is pricing in a premium on top of a premium.

The cost of capital for continued public growth is a critical counterweight. Boralex's aggressive expansion plan, which aims to double its capacity, requires substantial ongoing investment. The company has historically financed this through equity offerings, like the $175 million bought deal in 2020. A private buyer would inherit this capital-intensive growth trajectory but without the public market's ability to raise funds easily. The premium a buyer offers must therefore compensate for the loss of that public financing flexibility, making the required premium even higher.

This tension is reflected in management's actions. Instead of pursuing a full buyout, Boralex has authorized a normal course issuer bid (NCIB) to buy back up to 10% of its public float. This is a powerful signal. It suggests management believes the stock is undervalued relative to the company's underlying business, as they are using cash to repurchase shares at current prices. Yet they are choosing a partial, market-based mechanism over a full buyout. This implies that a full buyout at a premium is not the most efficient or perhaps even the most attractive path for returning capital to shareholders right now.

The bottom line is that the premium is already priced in. The stock's recent rally and the NCIB authorization show the market has already rewarded the growth narrative and the deal speculation. For a going-private transaction to be viable, a buyer would need to offer a substantial additional premium to justify the cost of capital and the loss of public market liquidity. Given the company's recent operational headwinds and the capital intensity of its plan, that required premium may be difficult to justify. The market's current setup leaves little room for the kind of extra upside a private buyer would need to demand.

Catalysts and Risks: The Path to 2030

The viability of a private deal for Boralex hinges on a single, capital-intensive journey: successfully navigating its ambitious 2030 capacity doubling plan. The primary catalyst is clear execution. The company has set a firm target to double its installed capacity, and its recent progress provides a roadmap. In 2025, Boralex commissioned several key projects, including the Limekiln wind farm in the UK and the Apuiat wind farm in Québec. More critically, it brought online the Hagersville battery energy storage system (300 MW), a project that has already been recognized for its innovation. The path forward includes the Clashindarroch Extension wind project in Scotland, which received ministerial approval last year and represents a major step in its UK expansion. Consistent commissioning of these projects is the tangible proof of progress that would validate the growth story for a private buyer.

Yet the key risk is a persistent pressure on the revenue stream that funds this expansion. The company's own financial results show the vulnerability. In fiscal 2025, EBITDA(A) fell by $29 million, a direct hit from lower prices under short-term power purchase agreements in France. This is not an isolated event but a structural headwind in a key market where Boralex has significant exposure. If short-term power prices in France and other core markets remain depressed, it will continue to squeeze margins and discretionary cash flows, making it harder to fund the aggressive development pipeline without further dilution or debt.

For now, the company is managing this tension. It has secured significant financing, closing over $1 billion in project financing in 2025, and has increased its subordinated debt. This financial flexibility is a necessary buffer, but it is a temporary one. The real test is whether Boralex can generate enough cash from operations to support its growth, or if it will be forced into a cycle of repeated equity raises-a dynamic that a private buyer would need to address. Investors and potential acquirers must watch for updates on development pipeline progress and new financing announcements. These are the signals that will indicate whether the growth trajectory is on track or if the capital-intensive, price-sensitive path is becoming untenable. The deal's viability is not a binary yes/no; it is a function of how well the company navigates this complex, high-stakes journey.